Vol 48 - N° 1 - mars 2013
P. 1-e3? Elsevier Masson SAS
Page :i
For a hospital pharmaceutical model
Page :1-2
M. Juste
Page :3
M. Juste, Le groupe « Standardisation et valorisation des activités de pharmacie clinique » de la SFPC
Effect of agomelatine on sedative-hypnotic drugs use
Page :4-11
F. Compagnat, C. Chalmendrier, E. Méjat, R. Rebrab, C. Nétillard, G. Martin, E. Tissot
Cost of switching a proprietary medicinal product in the purchasing process: An often-ignored selection criterion
Page :12-20
M.-A. Opsomer, V. Jost, P. Fagnoni, M.H. Guignard
Contamination control practices and qualification in a Tunisian centralized unit of parenteral nutrition
Page :21-26
M. Hergli, S. Bahri, H. Nouir, D. Hammami, A. Chekir, S. Sfar
Relevant activity and performance indicator for pharmacy compounding: Benchmarking for two oncology drugs compounding pharmacy laboratories
Page :27-36
C. Malbranche, S. Lamon, I. Roland, D. Jacob, M. Duban, C. Pernot
Implementing a hospital pharmacy Clinical Trials Unit (CTU) with ISO 9001: 2008 for Quality Management System
Page :37-49
G. Maillan, H. Carpenet, B. Girol, M.-A. de Vinzelles, G. Col, M. Javerliat, F. Renon-Carron
Characteristics of phone calls in a university hospital center pharmacy department
Page :50-52
A. Guérin, E. Caron, D. Lebel, J.-F. Bussières
Optimization of antibiotic therapy
Page :53-63
D. Breilh
Recommandations de bonne pratique en pharmacie clinique. Analyse d’ordonnance
Page :e1
M. Juste, for the group “Standardisation et valorisation des activité de pharmacie clinique” of the SFPC Pharmacie de Haut-Lévêque, CHU de Bordeaux, avenue de Magellan, 33604 Pessac cedex, France
Page :64-65
Page :66
F. Lagrange
Page :67
F. Lagrange
Page :67-68
F. Lagrange
Page :68-69
F. Lagrange
Page :70-71
Page :72
Page :73
Page :74
Mireille Jouannet, Hélène Barreteau